Seronegative rheumatoid arthritis (RA) is often misunderstood and underrecognized, and this leads to delays in diagnosis and treatment. Emerging studies highlight distinct features and unmet needs of seronegative RA, calling for increased awareness of the challenges faced by patients and the need for tailored therapeutic approaches to improve outcomes.
This is a preview of subscription content, access via your institution
Access options
Access Nature and 54 other Nature Portfolio journals
Get Nature+, our best-value online-access subscription
$32.99 / 30 days
cancel any time
Subscribe to this journal
Receive 12 print issues and online access
$189.00 per year
only $15.75 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to the full article PDF.
USD 39.95
Prices may be subject to local taxes which are calculated during checkout

References
Paroli, M. & Sirinian, M. I. When autoantibodies are missing: the challenge of seronegative rheumatoid arthritis. Antibodies 12, 69 (2023).
Myasoedova, E., Davis, J., Matteson, E. L. & Crowson, C. S. Is the epidemiology of rheumatoid arthritis changing? Results from a population-based incidence study, 1985–2014. Ann. Rheum. Dis. 79, 440–444 (2020).
Matthijssen, X. M. E., Huizinga, T. W. J. & van der Helm-van Mil, A. H. M. Increasing incidence of autoantibody-negative RA is replicated and is partly explained by an aging population. Ann. Rheum. Dis. 81, e69 (2022).
Soussi, B. G. et al. Incidence of seropositive and seronegative rheumatoid arthritis in Denmark: a nationwide population-based study. Scand. J. Rheumatol. 53, 316–324 (2024).
Muilu, P. et al. Increasing incidence and shifting profile of idiopathic inflammatory rheumatic diseases in adults during this millennium. Clin. Rheumatol. 38, 555–562 (2019).
Paalanen, K., Puolakka, K., Nikiphorou, E., Hannonen, P. & Sokka, T. Is seronegative rheumatoid arthritis true rheumatoid arthritis? A nationwide cohort study. Rheumatology 60, 2391–2395 (2021).
Paalanen, K. et al. Does early seronegative arthritis develop into rheumatoid arthritis? A 10-year observational study. Clin. Exp. Rheumatol. 37, 37–43 (2019).
Barra, L. et al. Prognosis of seronegative patients in a large prospective cohort of patients with early inflammatory arthritis. J. Rheumatol. 41, 2361–2369 (2014).
Matthijssen, X. M. E., Niemantsverdriet, E., Huizinga, T. W. J. & van der Helm-van Mil, A. H. M. Enhanced treatment strategies and distinct disease outcomes among autoantibody-positive and -negative rheumatoid arthritis patients over 25 years: a longitudinal cohort study in the Netherlands. PLoS Med. 17, e1003296 (2020).
Coffey, C. M., Crowson, C. S., Myasoedova, E., Matteson, E. L. & Davis, J. M. 3rd. Evidence of diagnostic and treatment delay in seronegative rheumatoid arthritis: missing the window of opportunity. Mayo Clin. Proc. 94, 2241–2248 (2019).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing interests.
Rights and permissions
About this article
Cite this article
Javed, I., Crowson, C.S. The apprehension of seronegative rheumatoid arthritis. Nat Rev Rheumatol 21, 575–576 (2025). https://doi.org/10.1038/s41584-025-01289-8
Published:
Version of record:
Issue date:
DOI: https://doi.org/10.1038/s41584-025-01289-8